Theriva Biologics (TOVX) Misses Q2 EPS by 193c

Theriva Biologics (NYSE: TOVX) reported Q2 EPS of ($1.93).

For earnings history and earnings-related data on Theriva Biologics (TOVX) click here.

You May Also Be Interested In

• Yatsen Holding (YSG) Reports Q2 Loss of $0.16
• Truist Securities Reiterates Buy Rating on Palo Alto Networks (PANW)
• GitLab Inc (GTLB) PT Raised to $55 at Rosenblatt, 'We remain buyers of the stock'